Hims & Hers Health Inc [NYSE: HIMS] jumped around 0.04 points on Thursday, while shares priced at $9.45 at the close of the session, up 0.43%. The company report on February 20, 2024 at 8:00 AM that Hims & Hers Names Dan Kenger as the Company’s First Chief Design Officer.
Longtime company leader ensures the brand is innovating and driving a digital-first, personalized health and wellness experience.
Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced Dan Kenger will join the company’s executive team as the first Chief Design Officer. Kenger currently serves as the SVP of Design at Hims & Hers and has been at the company since its founding.
Compared to the average trading volume of 2.67M shares, HIMS reached a trading volume of 3881683 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about Hims & Hers Health Inc [HIMS]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for HIMS shares is $10.45 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on HIMS stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Imperial Capital have made an estimate for Hims & Hers Health Inc shares, keeping their opinion on the stock as In-line, with their previous recommendation back on December 07, 2023. While these analysts kept the previous recommendation, TD Cowen raised their target price to Outperform. The new note on the price target was released on July 28, 2023, representing the official price target for Hims & Hers Health Inc stock. Previously, the target price had yet another raise to $10, while Robert W. Baird analysts kept a Neutral rating on HIMS stock. On February 09, 2023, analysts increased their price target for HIMS shares from 7 to 11.
The Average True Range (ATR) for Hims & Hers Health Inc is set at 0.40, with the Price to Sales ratio for HIMS stock in the period of the last 12 months amounting to 2.53. The Price to Book ratio for the last quarter was 6.10, with the Price to Cash per share for the same quarter was set at 1.00. Price to Free Cash Flow for HIMS in the course of the last twelve months was 74.56 with Quick ratio for the last quarter at 2.76.
How has HIMS stock performed recently?
Hims & Hers Health Inc [HIMS] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -5.41. With this latest performance, HIMS shares gained by 8.00% in over the last four-week period, additionally plugging by 40.21% over the last 6 months – not to mention a rise of 1.18% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for HIMS stock in for the last two-week period is set at 52.75, with the RSI for the last a single of trading hit 49.52, and the three-weeks RSI is set at 54.17 for Hims & Hers Health Inc [HIMS]. The present Moving Average for the last 50 days of trading for this stock 8.95, while it was recorded at 9.71 for the last single week of trading, and 8.07 for the last 200 days.
Hims & Hers Health Inc [HIMS]: Deeper insight into the fundamentals
Hims & Hers Health Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 2.76 and a Current Ratio set at 3.03.
Earnings analysis for Hims & Hers Health Inc [HIMS]
With the latest financial reports released by the company, Hims & Hers Health Inc posted -0.05/share EPS, while the average EPS was predicted by analysts to be reported at -0.07/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 28.60%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for HIMS.
Insider trade positions for Hims & Hers Health Inc [HIMS]
The top three institutional holders of HIMS stocks are: VANGUARD GROUP INC with ownership of 1.3 billion shares, which is approximately 8.2815%. BLACKROCK INC., holding 1.03 billion shares of the stock with an approximate value of $176.59 billion in HIMS stocks shares; and BERKSHIRE HATHAWAY INC, currently with $156.75 billion in HIMS stock with ownership which is approximately 5.8325%.
